leadf
logo-loader
viewBioLargo, Inc.

BioLargo says study reports its CupriDyne disinfectant kills the coronavirus in 10 minutes

BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive that its patented CupriDyne disinfectant was able to completely inactivate the SARS-CoV-2, the virus that causes COVID-19, in just 10 minutes.

Calvert says the results were achieved in a third-party study of a modified CupriDyne formula at the Galveston National Laboratory at the University of Texas Medical Branch. The group plans to file for EPA registration for the new faster-acting formula.

Quick facts: BioLargo, Inc.

Price: 0.1548 USD

OTCMKTS:BLGO
Market: OTCQB
Market Cap: $33.06 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioLargo, Inc. named herein, including the promotion by the Company of BioLargo, Inc. in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

BioLargo reveals 60% rise in 3Q revenue amidst roll-out of PPE disinfectant...

BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tell Proactive the group posted third-quarter results on Thursday that saw its revenue jump 60% year-over-year on the back of contributions from all four of its divisions including its subsidiary Clyra Medical Technologies. Clyra Medical Technologies...

1 week, 4 days ago

2 min read